Land: Armenien
Sprache: Englisch
Quelle: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
betamethasone (betamethasone valerate)
Arpimed LLC
D07AC01
betamethasone (betamethasone valerate)
1mg/g
ointment for topical use
15g aluminium tube
Prescription
Registered
2018-10-27
SUMMARY OF PRODUCT CHARACTERISTICS BETAMETHASONE 0.1% OINTMENT FOR TOPICAL USE 1.1 BRAND NAME – BETAMETHASONE 1.2 INTERNATIONAL NON-PROPERTY NAME - BETAMETHASONE 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 gram of ointment contains: active ingredient: betamethasone valerate equivalent to 1mg betamethasone. _ For a full list of excipients, see section 6.1 _ 3. PHARMACEUTICAL FORM Ointment. White to yellowish white odorless 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses. These include the following: Atopic dermatitis (including infantile atopic dermatitis) Nummular dermatitis (discoid eczema) Prurigo nodularis Psoriasis (excluding widespread plaque psoriasis) Lichen simplex chronicus (neurodermatitis) and lichen planus Seborrhoeic dermatitis Irritant or allergic contact dermatitis Discoid lupus erythematosus Adjunct to systemic steroid therapy in generalised erythroderma 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: Cutaneous Ointments are especially appropriate for dry, lichenified or scaly lesions. Apply thinly and gently rub in using only enough to cover the entire affected area once or twice daily for up to 4 weeks until improvement occurs, then reduce the frequency of application or change the treatment to a less potent preparation. Allow adequate time for absorption after each application before applying an emollient. In the more resistant lesions, such as the thickened plaques of psoriasis on elbows and knees, the effect of betamethasone valerate can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response in such lesions; thereafter, improvement can usually be maintained by regular application without occlusion. If the condition worsens or does not improve within Lesen Sie das vollständige Dokument